
Qiagen Offers Growth And Margin Leverage Beyond The Pandemic Deceleration (NYSE:QGEN)
Sascha Schuermann/Getty Images News As is the case with most diagnostics and life science companies, Qiagen (NYSE:QGEN) is going to be working off a bit of a hangover as COVID-19-related revenue decelerates further. On the […]